LUNG vs MPC · rev $83.8M vs P/E 16, rev $138.86B
Pulmonx Corp (LUNG) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
Pulmonx Corp (LUNG) is a medical devices company listed on US.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Latest reported LUNG revenue for 2024-12-31 was $83.8M. Net income was -$56.4M. Revenue was up 22.0% from 2023-12-31 to 2024-12-31. LUNG currently screens at market cap $111.9M.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
LUNG currently screens at market cap $111.9M. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the LUNG and MPC stock pages for the full models.
Not investment advice.